Cite
Dietrich L, Kibler M, Matsushita K, et al. Impact of Primary Hemostasis Disorders on Late Major Bleeding Events among Anticoagulated Atrial Fibrillation Patients Treated by TAVR. J Clin Med. 2021;11(1)doi: 10.3390/jcm11010212.
Dietrich, L., Kibler, M., Matsushita, K., Marchandot, B., Trimaille, A., Reydel, A., Diop, B., Truong, P. D., Trung, A. M., Trinh, A., Carmona, A., Hess, S., Jesel, L., Ohlmann, P., & Morel, O. (2021). Impact of Primary Hemostasis Disorders on Late Major Bleeding Events among Anticoagulated Atrial Fibrillation Patients Treated by TAVR. Journal of clinical medicine, 11(1), . https://doi.org/10.3390/jcm11010212
Dietrich, Laurent, et al. "Impact of Primary Hemostasis Disorders on Late Major Bleeding Events among Anticoagulated Atrial Fibrillation Patients Treated by TAVR." Journal of clinical medicine vol. 11,1 (2021). doi: https://doi.org/10.3390/jcm11010212
Dietrich L, Kibler M, Matsushita K, Marchandot B, Trimaille A, Reydel A, Diop B, Truong PD, Trung AM, Trinh A, Carmona A, Hess S, Jesel L, Ohlmann P, Morel O. Impact of Primary Hemostasis Disorders on Late Major Bleeding Events among Anticoagulated Atrial Fibrillation Patients Treated by TAVR. J Clin Med. 2021 Dec 31;11(1). doi: 10.3390/jcm11010212. PMID: 35011952; PMCID: PMC8746148.
Copy
Download .nbib